Mice were monitored for clinical abnormalities ( Supplemental Table 6 )
Roche with its 2024 acquisition of Carmot, and Pfizer, following its 2025 acquisition of Metsera, enter obesity and broaden their presence in cardiovascular/metabolic, while other large pharmaceutical companies prepare to follow later in the decade
It should never be stored at room temperature after mixing
All information provided on this website is for purely educational purposes only
CARNISURE 1GM INJECTION is used to manage carnitine deficiency, which can occur at birth, as a result of certain metabolic disorders, or as a result of a medical procedure such as hemodialysis
Phase 3 TRIUMPH results are expected in 2026 and 2027, and Health Canada approval is likely in 2027 or 2028 if the late data holds up